日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world use of emapalumab in hemophagocytic lymphohistiocytosis: a scoping review of published evidence

emapalumab 在噬血细胞性淋巴组织细胞增生症中的真实世界应用:已发表证据的范围综述

Gil, Charlotte; Abdoul, Hendy; Campagna, Raphaël; Guerini, Henri; Ieong, Estelle; Chagny, Franck; Bedin, Catherine; Roren, Alexandra; Lefèvre-Colau, Marie-Martine; Poiraudeau, Serge; Feydy, Antoine; Rannou, François; Nguyen, Christelle; Cox, Miriam; Umair, Hafiz; Zosmer, Maya; Williamson, Luke; Ninan, Ann; Huws, Gwenan; Jacobs, Alana; Naughton, Michael; Catão, Thaís; Gottgtroy, Carla; Marques, Amanda; Varela, Julianna; Danowski, Adriana; de Paula, Jenifer; dos Santos, Eliane; Lago, Elvira; Fialho, Beatriz; Maia, Maria de Lourdes; Al-Mashdali, Abdulrahman F; Mohamed, Fatihelmgib; Osman, Marwa; Abdelraof, Mujahid O; Al Rasheed, Mona; Salama, Hind; Mohamed, Shehab F; Yassin, Mohamed A

Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study

结合人口结构变化和基于年龄的耐药性流行情况,估算欧洲未来抗菌药物耐药性负担及其对目标的影响:一项建模研究

Waterlow, Naomi R; Chandler, Clare I R; Cooper, Ben S; Moore, Catrin E; Robotham, Julie V; Sartorius, Benn; Sharland, Michael; Knight, Gwenan M

In vitro activity of antibiotic monotherapy and combination therapy with bacteriophages against Staphylococcus aureus LVAD-driveline infections

体外抗生素单药治疗及与噬菌体联合治疗对金黄色葡萄球菌左心室辅助装置驱动线感染的活性

Molendijk, Michèle M; Verkaik, Nelianne J; de Vogel, Corné P; Lemmens-den Toom, Nicole; Knight, Gwenan M; Caliskan, Kadir; Bode, Lonneke G M; Verbon, Annelies; Koopmans, Marion P G; de Graaf, Miranda; van Wamel, Willem J B

Observational study of antibiotic prescribing patterns by age and sex in primary care in England: why we need to take this variation into account to evaluate antibiotic stewardship and predict AMR variation

一项关于英格兰初级保健中按年龄和性别划分的抗生素处方模式的观察性研究:为什么我们需要考虑这种差异来评估抗生素管理和预测抗菌药物耐药性变化

Waterlow, Naomi R; Ashfield, Tom; Knight, Gwenan M

Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis

氟喹诺酮类耐药性对多重耐药或利福平耐药结核病经验性治疗成本效益的影响

Kim, Chaelin; Sweeney, Sedona; Sohn, Hojoon; Knight, Gwenan M; McQuaid, C Finn

Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillance

利用常规临床数据进行抗菌药物耐药性监测的工具和挑战

Holt, Kathryn E; Carey, Megan E; Chandler, Clare; Cross, James H; Dyson, Zoe A; Furnham, Nicholas; Glover, Rebecca E; Virgo, Mollie; Knight, Gwenan M

A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis

联合国抗菌素耐药性问题高级别会议的成功召开必须以2023年联合国结核病问题高级别会议为基础。

Cirillo, Daniela; Anthony, Richard; Gagneux, Sebastien; Horsburgh, C Robert Jr; Hasan, Rumina; Darboe, Saffiatou; Laniado-Laborin, Rafael; Probandari, Ari; Tukvadze, Nestani; Arcêncio, Ricardo A; Bimba, John S; Brighenti, Susanna; Chesov, Dumitru; Chiang, Chen-Yuan; Kalmambetova, Gulmira; Knight, Gwenan; Konstantynovska, Olha; Kruse, Alexandra; Lange, Christoph; Mayanja-Kizza, Harriet; McBryde, Emma; Min, Jinsoo; Sanchez-Montalva, Adrian; Sulis, Giorgia; Tsogt, Bazarragchaa; Van Der Walt, Martie; Yeboah-Manu, Dorothy; Hauser, Janika

Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study

欧洲29个国家血液感染中抗菌药物耐药性的流行情况(按年龄和性别划分):一项观察性研究

Waterlow, Naomi R; Cooper, Ben S; Robotham, Julie V; Knight, Gwenan Mary

Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review

耐药结核病的数学模型缺乏细菌异质性:一项系统性综述

Fuller, Naomi M; McQuaid, Christopher F; Harker, Martin J; Weerasuriya, Chathika K; McHugh, Timothy D; Knight, Gwenan M

The contribution of animal antibiotic use to antibiotic resistance in human infections: Panel evidence from Denmark

动物用抗生素对人类感染抗生素耐药性的影响:来自丹麦的专家组证据

Emes, Eve; Belay, Dagim; Knight, Gwenan M